Herbertz, S., Sawyer, J. S., Stauber, A. J., Gueorguieva, I., Driscoll, K. E., Estrem, S. T., . . . Lahn, M. M. (2015). Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Devel Ther.
Citação norma ChicagoHerbertz, Stephan, et al. "Clinical Development of Galunisertib (LY2157299 Monohydrate), a Small Molecule Inhibitor of Transforming Growth Factor-beta Signaling Pathway." Drug Des Devel Ther 2015.
Citação norma MLAHerbertz, Stephan, et al. "Clinical Development of Galunisertib (LY2157299 Monohydrate), a Small Molecule Inhibitor of Transforming Growth Factor-beta Signaling Pathway." Drug Des Devel Ther 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.